We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Allergan to Acquire Tobira for $1.695Bn

News   Sep 20, 2016

 
Allergan to Acquire Tobira for $1.695Bn
 
 
 

RELATED ARTICLES

Green Tea Acts as a "Remote Control" To Switch on Cell Therapy

News

In a new study published today in Science Advances, researchers from East China Normal University have created an elegant system for activating genetically edited cells using green tea.

READ MORE

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE